PP Tak

Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response

Rogier M. Thurlings, Koen Vos, C A Wijbrandts et al. · Annals of the Rheumatic Diseases · 2007 · 329 citations · Full text

Medicine, Immunology, Internal Medicine +17

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies

Edward Keystone, Paul Emery, Charles Peterfy et al. · Annals of the Rheumatic Diseases · 2008 · 240 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Receptor activator NF-κB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis

Tania N. Crotti, Malcolm Smith, Helen Weedon et al. · Annals of the Rheumatic Diseases · 2002 · 185 citations · Full text

Medicine, Immunology, Pathology +11

Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis

Maarten C. Kraan, Tom Smeets, Muaz Loon et al. · Annals of the Rheumatic Diseases · 2004 · 64 citations · Full text

Medicine, Immunology, Pharmacology +17

Temporal changes in salivary glands of non‐obese diabetic mice as a model for Sjögren’s syndrome

Nienke Roescher, BM Lodde, JL Vosters et al. · Oral Diseases · 2011 · 56 citations

Life Sciences, Immunology, Pathobiology +17